Last reviewed: June 24, 2026
Last updated: June 24, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide has become one of the most effective medications for weight management, with clinical trials showing average weight loss of 15% of body weight over 68 weeks. Success with semaglutide depends not just on the medication itself, but on how you use it alongside lifestyle changes and personalized health insights. PlexusDx provides access to compounded semaglutide injections from licensed 503A pharmacies, plus optional genetic testing to help identify your individual response patterns.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
How Semaglutide Works for Weight Loss
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that reduces hunger signals in the brain and slows stomach emptying. This dual action creates prolonged feelings of fullness, making it easier to eat fewer calories without constant willpower. The medication also improves blood sugar control, which stabilizes energy levels and reduces cravings throughout the day.
The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Creating a Semaglutide Dosing Protocol That Works
Most semaglutide protocols begin with a low starting dose and increase gradually over 4–16 weeks to allow your body to adapt and minimize side effects. The standard approach starts at 0.25 mg once weekly, with increases every 4 weeks until you reach your therapeutic dose or experience adequate hunger suppression. Your dose may need to go up. Your price won't—PlexusDx charges a flat monthly rate regardless of the dose level you eventually reach.
The right dose is the one that reduces your appetite to a manageable level while keeping side effects tolerable. This is highly individual and can shift over time as your body adapts or your weight changes. Working with a healthcare provider who understands GLP-1 therapy—and who can review your genetic testing results—helps ensure your dose stays aligned with your goals, not just a one-size-fits-all protocol.
Nutrition and Exercise Strategies on Semaglutide
Semaglutide reduces hunger, but it doesn't eliminate the need for intentional food choices. Prioritize protein at every meal—aim for 25–35 grams per meal—to preserve muscle mass during weight loss and maximize satiety. Include plenty of non-starchy vegetables, whole grains, and healthy fats, and eat slowly to avoid nausea that can occur if you consume too quickly or too much at once.
Exercise enhances semaglutide's weight loss effects by preserving lean muscle, improving insulin sensitivity, and boosting metabolism. Start with moderate aerobic activity (150 minutes per week) and add resistance training 2–3 times weekly once you adjust to the medication. Many patients find that reduced hunger makes it easier to sustain an exercise routine, creating a positive feedback loop where medication and movement reinforce each other.
Personalized Treatment with Genetic Insight
PlexusDx's Precision Peptide Genetic Test analyzes key variants in appetite-control and metabolic pathways—including the GLP1R rs6923761 variant, the FTO rs9939609 variant, and the MC4R rs17782313 variant—that influence how your body responds to semaglutide. These genetic insights map 14 metabolic pathways and 49 peptide-related factors, giving your provider a roadmap for optimizing your therapy from the start.
The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Managing Side Effects for Long-Term Success
Nausea, constipation, and loss of appetite for foods you once enjoyed are common in the first 2–4 weeks on semaglutide. These effects usually fade as your body adapts, but staying hydrated, eating smaller meals, and consuming soluble fiber can ease symptoms. If side effects persist or worsen, your provider may slow the dose increase or adjust your protocol—another reason why personalized monitoring matters more than strict dose escalation.
Some patients experience muscle loss during rapid weight loss on semaglutide. Adequate protein intake (1.2–1.6 grams per kilogram of body weight) and consistent resistance training minimize this risk and help you retain the lean mass that drives your metabolism. Regular check-ins with your healthcare team ensure that side effects aren't masking a deeper issue and that your weight loss is progressing at a healthy, sustainable pace.
Accessing Compounded Semaglutide Without Insurance
PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and are prepared by licensed 503A compounding pharmacies in all 50 states. No insurance is required, no membership fees apply, and HSA and FSA accounts can be used to cover the cost, making the medication accessible to a wide range of patients. The straightforward monthly pricing removes uncertainty and lets you budget for your treatment with confidence.
Compounded medications from licensed 503A pharmacies follow the same FDA manufacturing standards and quality controls as brand-name drugs, even though compounded semaglutide itself is not FDA-approved. PlexusDx partners exclusively with accredited compounders to ensure purity, potency, and sterility in every dose. Your prescription can be filled and shipped directly to your home, and PlexusDx's care team is available to answer questions about your treatment at any stage.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.
Frequently Asked Questions
How much weight can I expect to lose on semaglutide?
No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
What is the difference between compounded semaglutide and brand-name Ozempic?
Both contain the same active ingredient (semaglutide), but brand-name Ozempic is FDA-approved while compounded semaglutide is made by licensed 503A pharmacies to meet the same quality and safety standards. Compounded semaglutide is significantly more affordable and available without insurance, making it accessible to more patients who need GLP-1 therapy.
How much does semaglutide cost at PlexusDx?
PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan, with pricing flat regardless of your dose level. HSA and FSA accounts are accepted, and no insurance or membership fee is required. The Precision Peptide Genetic Test is an optional $298.
What are the most common side effects of semaglutide?
Nausea, constipation, decreased appetite, and vomiting are the most common side effects, typically appearing in the first 2–4 weeks and fading as your body adjusts. Staying hydrated, eating smaller meals, and increasing soluble fiber intake help manage symptoms. Serious side effects are rare, but discuss any persistent or severe symptoms with your healthcare provider immediately.
What does the Precision Peptide Genetic Test tell me about my semaglutide response?
No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Master Your Nutrition: How to Eat When Taking Wegovy for Lasting Success
Your First Ozempic Dose: Understanding What to Expect and How to Thrive